U.K.’s ACCORD platform trial to feed therapies into COVID-19 master protocols

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

The U.K. has launched the ACCORD platform trial to quickly test potential COVID-19 treatments that could be fast-tracked into larger master protocol trials.

The Accelerating COVID-19 Research & Development platform (ACCORD) study is

Read the full 326 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers